Related Experiment Video
Updated: Jun 13, 2026

Mouse Model of Acute to Chronic Kidney Disease Transition Induced by Renal Ischemia/Reperfusion Injury
Published on: February 10, 2026
Chronic kidney disease bone and mineral disorder (CKD-MBD) in apolipoprotein E-deficient mice with chronic renal
Igor G Nikolov1, Nobuhiko Joki, Thao Nguyen-Khoa
1Inserm ERI-12, University of Picardie, Amiens, France. nikolov_igor@yahoo.com
Insights
Apolipoprotein E deficiency increases bone mass in mice, with chronic renal failure (CRF) further elevating bone mass but decreasing bone density. These findings suggest a link between bone disease and vascular complications in chronic kidney disease (CKD).
Area of Science:
- Nephrology
- Bone Metabolism
- Cardiovascular Disease
Background:
- Chronic kidney disease (CKD) is linked to mineral and bone disorders (MBD), including renal osteodystrophy and vascular calcifications.
- These MBDs may contribute to the high cardiovascular disease (CVD) risk in uremic patients.
- Apolipoprotein E (ApoE) plays a role in both bone and lipid metabolism, making ApoE-deficient mice a relevant model for studying CKD-related bone and vascular issues.
Purpose of the Study:
- To characterize bone lesions in CKD-apolipoprotein E-deficient (apoE(-/-)) mice.
- To analyze the relationship between bone lesions and vascular calcifications in this model.
- To compare the effects of chronic renal failure (CRF) on bone in apoE(-/-) mice versus wild-type (WT) mice.
Main Methods:
- Female apoE(-/-) and WT mice underwent CRF creation or sham surgery.
- Eight weeks post-surgery, serum, aorta, and femur samples were collected.
- Femurs were analyzed using 3D microtomography (microCT) and bone histomorphometry (BHM); aortas were analyzed for atherosclerotic and calcified lesions.
Main Results:
- ApoE deficiency increased cortical and trabecular bone mass in mice.
- CRF further increased trabecular bone volume and osteoid surface in both genotypes.
- Positive correlations were observed between atherosclerotic lesions and bone volume, and between plaque calcification and osteoclast parameters in apoE(-/-) mice.
Conclusions:
- ApoE deficiency increases bone mass and volumetric mineral density in female mice.
- CRF exacerbates bone mass increase but decreases bone mineral density, with signs of osteitis fibrosa.
- Findings support a link between bone and vascular disease in CKD, warranting further investigation.
Background:
Chronic kidney disease (CKD) is associated with disorders of mineral and bone metabolism (MBD) which include renal osteodystrophy and vascular calcifications. This is of clinical concern because the high risk of cardiovascular (CVD) complications observed in uremic patients may be linked with bone disease. In this context, our aim was to characterize the bone lesions in CKD-apolipoprotein E-deficient mice (apoE(-/-)) and analyze their relationships with the vascular calcifications which these animals develop rapidly in this model. With ApoE being also involved in bone metabolism, we compared the effects of CRF on the bone of apoE(-/-) mice to those observed in wild type mice (WT) of the same genetic background, C57/BL6.
Methods:
After CRF creation or sham surgery, 10 week-old female apoE(-/-) and WT mice were randomized to 4 groups (n=10-14/group) and fed with standard diet. Eight weeks later, animals were euthanized. Serum, aorta and femur were sampled. Femurs were imaged with 3-dimensional microtomography (microCT) and processed for bone histomorphometry (BHM). Additional quantitative histology was performed on atherosclerotic and calcified lesions in the aortas of apoE(-/-) mice.
Results:
First, apoE(-/-) mice exhibited higher cortical (10%) and trabecular (31%) bone mass than WT. CRF led to a further increase in trabecular BV/TV in WT and in apoE(-/-) mice (10.2% and 77.2%, respectively). We observed a similar increase in osteoid surface and osteoblastic parameters in CRF mice of both genotypes while resorption parameters were less augmented by CRF in apoE(-/-) mice. Finally, based on either BHM or microCT we found positive correlations between the extent of atherosclerotic lesions and bone volume parameters, and between the size of plaque calcification and osteoclast parameters in apoE(-/-) mice.
Conclusion:
ApoE deficiency is associated with an increase in bone mass and volumetric mineral density in 20 week-old female mice. Bone mass is further increased, whereas bone mineral density is decreased, in response to CRF in association with histological features of osteitis fibrosa. Finally, our findings of correlations between changes in bone and aortic lesions in apoE(-/-) mice, are compatible with the hypothesis of a link between bone and vascular disease and require further study.
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease III: Interprofessional Care
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Diabetic Nephropathy

